APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cardiac AI-assisted Diagnosis

Compare research editions
View pricing & licenses

Selected research

Industry Research

Cardiac AI-assisted Diagnosis Industry Research Report 2026

5 March 2026128 pages

Choose your research edition.

Industry ResearchCardiac AI-assisted Diagnosis Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Cardiac AI-assisted Diagnosis Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Cardiac AI-assisted Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cardiac AI-assisted Diagnosis Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Cardiac AI-assisted Diagnosis Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Cardiac AI-assisted Diagnosis market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Cardiac AI-assisted Diagnosis market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Cardiac AI-assisted Diagnosis market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Cardiac AI-assisted Diagnosis market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Cardiac AI-assisted Diagnosis include Lepu Medical, G K Healthcare, Sense Time, United Imaging, Infervision, Shukun, FOSUN AITROX, NANO-X and MyCardium AI, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Cardiac AI-assisted Diagnosis market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cardiac AI-assisted Diagnosis.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Cardiac AI-assisted Diagnosis Market by Company

Lepu Medical

G K Healthcare

Sense Time

United Imaging

Infervision

Shukun

FOSUN AITROX

NANO-X

MyCardium AI

VUNO

Caption Care

UltraSight

Ultromics

Cleerly

Elucid

DiA Imaging Analysis

Koninklijke Philips N.V

Fujifilm

Cardiac AI-assisted Diagnosis Segment by Type

Cloud-based

On-Primes

Cardiac AI-assisted Diagnosis Segment by Application

Hospital

Clinic

Imaging Center

Cardiac AI-assisted Diagnosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiac AI-assisted Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cardiac AI-assisted Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiac AI-assisted Diagnosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Cardiac AI-assisted Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cardiac AI-assisted Diagnosis Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Cardiac AI-assisted Diagnosis Revenue Market Share by Type (2021-2026) Table 7. Global Cardiac AI-assisted Diagnosis Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Cardiac AI-assisted Diagnosis Revenue Market Share by Type (2027-2032) Table 9. Global Cardiac AI-assisted Diagnosis Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Cardiac AI-assisted Diagnosis Revenue Market Share by Application (2021-2026) Table 11. Global Cardiac AI-assisted Diagnosis Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Cardiac AI-assisted Diagnosis Revenue Market Share by Application (2027-2032) Table 13. Global Cardiac AI-assisted Diagnosis Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Cardiac AI-assisted Diagnosis Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Cardiac AI-assisted Diagnosis Market Share by Region (2021-2026) Table 16. Global Cardiac AI-assisted Diagnosis Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Cardiac AI-assisted Diagnosis Market Share by Region (2027-2032) Table 18. Cardiac AI-assisted Diagnosis Industry Trends Table 19. Cardiac AI-assisted Diagnosis Industry Drivers Table 20. Cardiac AI-assisted Diagnosis Industry Opportunities and Challenges Table 21. Cardiac AI-assisted Diagnosis Market Restraints Table 22. Global Top Cardiac AI-assisted Diagnosis Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Cardiac AI-assisted Diagnosis Revenue Market Share by Players (2021-2026) Table 24. Global Cardiac AI-assisted Diagnosis Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Cardiac AI-assisted Diagnosis, Headquarters and Area Served Table 26. Global Cardiac AI-assisted Diagnosis Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Cardiac AI-assisted Diagnosis by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Cardiac AI-assisted Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Cardiac AI-assisted Diagnosis Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Cardiac AI-assisted Diagnosis Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Cardiac AI-assisted Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Cardiac AI-assisted Diagnosis Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Cardiac AI-assisted Diagnosis Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Cardiac AI-assisted Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Cardiac AI-assisted Diagnosis Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Cardiac AI-assisted Diagnosis Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Cardiac AI-assisted Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Cardiac AI-assisted Diagnosis Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Cardiac AI-assisted Diagnosis Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Cardiac AI-assisted Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Cardiac AI-assisted Diagnosis Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Cardiac AI-assisted Diagnosis Market Size by Country (2027-2032) & (US$ Million) Table 45. Lepu Medical Company Information Table 46. Lepu Medical Business Overview Table 47. Lepu Medical Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026) & (US$ Million) Table 48. Lepu Medical Cardiac AI-assisted Diagnosis Product Portfolio Table 49. Lepu Medical Recent Developments Table 50. G K Healthcare Company Information Table 51. G K Healthcare Business Overview Table 52. G K Healthcare Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026) & (US$ Million) Table 53. G K Healthcare Cardiac AI-assisted Diagnosis Product Portfolio Table 54. G K Healthcare Recent Developments Table 55. Sense Time Company Information Table 56. Sense Time Business Overview Table 57. Sense Time Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026) & (US$ Million) Table 58. Sense Time Cardiac AI-assisted Diagnosis Product Portfolio Table 59. Sense Time Recent Developments Table 60. United Imaging Company Information Table 61. United Imaging Business Overview Table 62. United Imaging Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026) & (US$ Million) Table 63. United Imaging Cardiac AI-assisted Diagnosis Product Portfolio Table 64. United Imaging Recent Developments Table 65. Infervision Company Information Table 66. Infervision Business Overview Table 67. Infervision Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026) & (US$ Million) Table 68. Infervision Cardiac AI-assisted Diagnosis Product Portfolio Table 69. Infervision Recent Developments Table 70. Shukun Company Information Table 71. Shukun Business Overview Table 72. Shukun Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026) & (US$ Million) Table 73. Shukun Cardiac AI-assisted Diagnosis Product Portfolio Table 74. Shukun Recent Developments Table 75. FOSUN AITROX Company Information Table 76. FOSUN AITROX Business Overview Table 77. FOSUN AITROX Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026) & (US$ Million) Table 78. FOSUN AITROX Cardiac AI-assisted Diagnosis Product Portfolio Table 79. FOSUN AITROX Recent Developments Table 80. NANO-X Company Information Table 81. NANO-X Business Overview Table 82. NANO-X Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026) & (US$ Million) Table 83. NANO-X Cardiac AI-assisted Diagnosis Product Portfolio Table 84. NANO-X Recent Developments Table 85. MyCardium AI Company Information Table 86. MyCardium AI Business Overview Table 87. MyCardium AI Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026) & (US$ Million) Table 88. MyCardium AI Cardiac AI-assisted Diagnosis Product Portfolio Table 89. MyCardium AI Recent Developments Table 90. VUNO Company Information Table 91. VUNO Business Overview Table 92. VUNO Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026) & (US$ Million) Table 93. VUNO Cardiac AI-assisted Diagnosis Product Portfolio Table 94. VUNO Recent Developments Table 95. Caption Care Company Information Table 96. Caption Care Business Overview Table 97. Caption Care Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026) & (US$ Million) Table 98. Caption Care Cardiac AI-assisted Diagnosis Product Portfolio Table 99. Caption Care Recent Developments Table 100. UltraSight Company Information Table 101. UltraSight Business Overview Table 102. UltraSight Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026) & (US$ Million) Table 103. UltraSight Cardiac AI-assisted Diagnosis Product Portfolio Table 104. UltraSight Recent Developments Table 105. Ultromics Company Information Table 106. Ultromics Business Overview Table 107. Ultromics Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026) & (US$ Million) Table 108. Ultromics Cardiac AI-assisted Diagnosis Product Portfolio Table 109. Ultromics Recent Developments Table 110. Cleerly Company Information Table 111. Cleerly Business Overview Table 112. Cleerly Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026) & (US$ Million) Table 113. Cleerly Cardiac AI-assisted Diagnosis Product Portfolio Table 114. Cleerly Recent Developments Table 115. Elucid Company Information Table 116. Elucid Business Overview Table 117. Elucid Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026) & (US$ Million) Table 118. Elucid Cardiac AI-assisted Diagnosis Product Portfolio Table 119. Elucid Recent Developments Table 120. DiA Imaging Analysis Company Information Table 121. DiA Imaging Analysis Business Overview Table 122. DiA Imaging Analysis Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026) & (US$ Million) Table 123. DiA Imaging Analysis Cardiac AI-assisted Diagnosis Product Portfolio Table 124. DiA Imaging Analysis Recent Developments Table 125. Koninklijke Philips N.V Company Information Table 126. Koninklijke Philips N.V Business Overview Table 127. Koninklijke Philips N.V Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026) & (US$ Million) Table 128. Koninklijke Philips N.V Cardiac AI-assisted Diagnosis Product Portfolio Table 129. Koninklijke Philips N.V Recent Developments Table 130. Fujifilm Company Information Table 131. Fujifilm Business Overview Table 132. Fujifilm Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026) & (US$ Million) Table 133. Fujifilm Cardiac AI-assisted Diagnosis Product Portfolio Table 134. Fujifilm Recent Developments Table 135. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Cardiac AI-assisted Diagnosis Product Image Figure 5. Global Cardiac AI-assisted Diagnosis Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Cardiac AI-assisted Diagnosis Market Share by Type: 2025 VS 2032 Figure 7. Cloud-based Product Figure 8. On-Primes Product Figure 9. Global Cardiac AI-assisted Diagnosis Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Cardiac AI-assisted Diagnosis Market Share by Application: 2025 VS 2032 Figure 11. Hospital Product Figure 12. Clinic Product Figure 13. Imaging Center Product Figure 14. Global Cardiac AI-assisted Diagnosis Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 15. Global Cardiac AI-assisted Diagnosis Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Cardiac AI-assisted Diagnosis Market Share by Region: 2025 VS 2032 Figure 17. Global Cardiac AI-assisted Diagnosis Market Share by Players in 2025 Figure 18. Global Cardiac AI-assisted Diagnosis Manufacturers Established Date Figure 19. Global Top 5 and 10 Cardiac AI-assisted Diagnosis Players Market Share by Revenue in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. North America Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Cardiac AI-assisted Diagnosis Market Share by Country (2021-2032) Figure 23. United States Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Canada Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Mexico Cardiac AI-assisted Diagnosis Market Share by Country (2021-2032) Figure 26. Europe Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Europe Cardiac AI-assisted Diagnosis Market Share by Country (2021-2032) Figure 28. Germany Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. France Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. U.K. Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Italy Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Spain Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Russia Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Netherlands Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Nordic Countries Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Cardiac AI-assisted Diagnosis Market Share by Country (2021-2032) Figure 38. China Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Japan Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. South Korea Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. India Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. India Cardiac AI-assisted Diagnosis Market Share by Country (2021-2032) Figure 43. Australia Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. China Taiwan Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. Southeast Asia Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. South America Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South America Cardiac AI-assisted Diagnosis Market Share by Country (2021-2032) Figure 48. Brazil Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. Argentina Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Chile Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Colombia Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Peru Cardiac AI-assisted Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Lepu Medical Revenue Growth Rate in Cardiac AI-assisted Diagnosis Business (2021-2026) Figure 54. G K Healthcare Revenue Growth Rate in Cardiac AI-assisted Diagnosis Business (2021-2026) Figure 55. Sense Time Revenue Growth Rate in Cardiac AI-assisted Diagnosis Business (2021-2026) Figure 56. United Imaging Revenue Growth Rate in Cardiac AI-assisted Diagnosis Business (2021-2026) Figure 57. Infervision Revenue Growth Rate in Cardiac AI-assisted Diagnosis Business (2021-2026) Figure 58. Shukun Revenue Growth Rate in Cardiac AI-assisted Diagnosis Business (2021-2026) Figure 59. FOSUN AITROX Revenue Growth Rate in Cardiac AI-assisted Diagnosis Business (2021-2026) Figure 60. NANO-X Revenue Growth Rate in Cardiac AI-assisted Diagnosis Business (2021-2026) Figure 61. MyCardium AI Revenue Growth Rate in Cardiac AI-assisted Diagnosis Business (2021-2026) Figure 62. VUNO Revenue Growth Rate in Cardiac AI-assisted Diagnosis Business (2021-2026) Figure 63. Caption Care Revenue Growth Rate in Cardiac AI-assisted Diagnosis Business (2021-2026) Figure 64. UltraSight Revenue Growth Rate in Cardiac AI-assisted Diagnosis Business (2021-2026) Figure 65. Ultromics Revenue Growth Rate in Cardiac AI-assisted Diagnosis Business (2021-2026) Figure 66. Cleerly Revenue Growth Rate in Cardiac AI-assisted Diagnosis Business (2021-2026) Figure 67. Elucid Revenue Growth Rate in Cardiac AI-assisted Diagnosis Business (2021-2026) Figure 68. DiA Imaging Analysis Revenue Growth Rate in Cardiac AI-assisted Diagnosis Business (2021-2026) Figure 69. Koninklijke Philips N.V Revenue Growth Rate in Cardiac AI-assisted Diagnosis Business (2021-2026) Figure 70. Fujifilm Revenue Growth Rate in Cardiac AI-assisted Diagnosis Business (2021-2026)

Scope & coverage.

Types
  • Cloud-based
  • On-Primes
Applications
  • Hospital
  • Clinic
  • Imaging Center
Companies covered
  • Lepu Medical
  • G K Healthcare
  • Sense Time
  • United Imaging
  • Infervision
  • Shukun
  • FOSUN AITROX
  • NANO-X
  • MyCardium AI
  • VUNO
  • Caption Care
  • UltraSight
  • Ultromics
  • Cleerly
  • Elucid
  • DiA Imaging Analysis
  • Koninklijke Philips N.V
  • Fujifilm

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Cardiac AI-assisted Diagnosis by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Cloud-based
  5. 2.2.3 On-Primes
  6. 2.3 Cardiac AI-assisted Diagnosis by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  8. 2.3.2 Hospital
  9. 2.3.3 Clinic
  10. 2.3.4 Imaging Center
  11. 2.4 Assumptions and Limitations
3 Cardiac AI-assisted Diagnosis Breakdown Data by Type
  1. 3.1 Global Cardiac AI-assisted Diagnosis Historic Market Size by Type (2021-2026)
  2. 3.2 Global Cardiac AI-assisted Diagnosis Forecasted Market Size by Type (2027-2032)
4 Cardiac AI-assisted Diagnosis Breakdown Data by Application
  1. 4.1 Global Cardiac AI-assisted Diagnosis Historic Market Size by Application (2021-2026)
  2. 4.2 Global Cardiac AI-assisted Diagnosis Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Cardiac AI-assisted Diagnosis Market Perspective (2021-2032)
  2. 5.2 Global Cardiac AI-assisted Diagnosis Growth Trends by Region
  3. 5.2.1 Global Cardiac AI-assisted Diagnosis Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Cardiac AI-assisted Diagnosis Historic Market Size by Region (2021-2026)
  5. 5.2.3 Cardiac AI-assisted Diagnosis Forecasted Market Size by Region (2027-2032)
  6. 5.3 Cardiac AI-assisted Diagnosis Market Dynamics
  7. 5.3.1 Cardiac AI-assisted Diagnosis Industry Trends
  8. 5.3.2 Cardiac AI-assisted Diagnosis Market Drivers
  9. 5.3.3 Cardiac AI-assisted Diagnosis Market Challenges
  10. 5.3.4 Cardiac AI-assisted Diagnosis Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Cardiac AI-assisted Diagnosis Players by Revenue
  2. 6.1.1 Global Top Cardiac AI-assisted Diagnosis Players by Revenue (2021-2026)
  3. 6.1.2 Global Cardiac AI-assisted Diagnosis Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Cardiac AI-assisted Diagnosis Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Cardiac AI-assisted Diagnosis Head Office and Area Served
  6. 6.4 Global Cardiac AI-assisted Diagnosis Players, Product Type & Application
  7. 6.5 Global Cardiac AI-assisted Diagnosis Manufacturers Established Date
  8. 6.6 Global Cardiac AI-assisted Diagnosis Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Cardiac AI-assisted Diagnosis Market Size (2021-2032)
  2. 7.2 North America Cardiac AI-assisted Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Cardiac AI-assisted Diagnosis Market Size by Country (2021-2026)
  4. 7.4 North America Cardiac AI-assisted Diagnosis Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Cardiac AI-assisted Diagnosis Market Size (2021-2032)
  2. 8.2 Europe Cardiac AI-assisted Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Cardiac AI-assisted Diagnosis Market Size by Country (2021-2026)
  4. 8.4 Europe Cardiac AI-assisted Diagnosis Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Cardiac AI-assisted Diagnosis Market Size (2021-2032)
  2. 9.2 Asia-Pacific Cardiac AI-assisted Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Cardiac AI-assisted Diagnosis Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Cardiac AI-assisted Diagnosis Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Cardiac AI-assisted Diagnosis Market Size (2021-2032)
  2. 10.2 South America Cardiac AI-assisted Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Cardiac AI-assisted Diagnosis Market Size by Country (2021-2026)
  4. 10.4 South America Cardiac AI-assisted Diagnosis Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Cardiac AI-assisted Diagnosis Market Size (2021-2032)
  2. 11.2 Middle East & Africa Cardiac AI-assisted Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Cardiac AI-assisted Diagnosis Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Cardiac AI-assisted Diagnosis Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Lepu Medical
  2. 12.1.1 Lepu Medical Company Information
  3. 12.1.2 Lepu Medical Business Overview
  4. 12.1.3 Lepu Medical Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026)
  5. 12.1.4 Lepu Medical Cardiac AI-assisted Diagnosis Product Portfolio
  6. 12.1.5 Lepu Medical Recent Developments
  7. 12.2 G K Healthcare
  8. 12.2.1 G K Healthcare Company Information
  9. 12.2.2 G K Healthcare Business Overview
  10. 12.2.3 G K Healthcare Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026)
  11. 12.2.4 G K Healthcare Cardiac AI-assisted Diagnosis Product Portfolio
  12. 12.2.5 G K Healthcare Recent Developments
  13. 12.3 Sense Time
  14. 12.3.1 Sense Time Company Information
  15. 12.3.2 Sense Time Business Overview
  16. 12.3.3 Sense Time Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026)
  17. 12.3.4 Sense Time Cardiac AI-assisted Diagnosis Product Portfolio
  18. 12.3.5 Sense Time Recent Developments
  19. 12.4 United Imaging
  20. 12.4.1 United Imaging Company Information
  21. 12.4.2 United Imaging Business Overview
  22. 12.4.3 United Imaging Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026)
  23. 12.4.4 United Imaging Cardiac AI-assisted Diagnosis Product Portfolio
  24. 12.4.5 United Imaging Recent Developments
  25. 12.5 Infervision
  26. 12.5.1 Infervision Company Information
  27. 12.5.2 Infervision Business Overview
  28. 12.5.3 Infervision Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026)
  29. 12.5.4 Infervision Cardiac AI-assisted Diagnosis Product Portfolio
  30. 12.5.5 Infervision Recent Developments
  31. 12.6 Shukun
  32. 12.6.1 Shukun Company Information
  33. 12.6.2 Shukun Business Overview
  34. 12.6.3 Shukun Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026)
  35. 12.6.4 Shukun Cardiac AI-assisted Diagnosis Product Portfolio
  36. 12.6.5 Shukun Recent Developments
  37. 12.7 FOSUN AITROX
  38. 12.7.1 FOSUN AITROX Company Information
  39. 12.7.2 FOSUN AITROX Business Overview
  40. 12.7.3 FOSUN AITROX Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026)
  41. 12.7.4 FOSUN AITROX Cardiac AI-assisted Diagnosis Product Portfolio
  42. 12.7.5 FOSUN AITROX Recent Developments
  43. 12.8 NANO-X
  44. 12.8.1 NANO-X Company Information
  45. 12.8.2 NANO-X Business Overview
  46. 12.8.3 NANO-X Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026)
  47. 12.8.4 NANO-X Cardiac AI-assisted Diagnosis Product Portfolio
  48. 12.8.5 NANO-X Recent Developments
  49. 12.9 MyCardium AI
  50. 12.9.1 MyCardium AI Company Information
  51. 12.9.2 MyCardium AI Business Overview
  52. 12.9.3 MyCardium AI Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026)
  53. 12.9.4 MyCardium AI Cardiac AI-assisted Diagnosis Product Portfolio
  54. 12.9.5 MyCardium AI Recent Developments
  55. 12.10 VUNO
  56. 12.10.1 VUNO Company Information
  57. 12.10.2 VUNO Business Overview
  58. 12.10.3 VUNO Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026)
  59. 12.10.4 VUNO Cardiac AI-assisted Diagnosis Product Portfolio
  60. 12.10.5 VUNO Recent Developments
  61. 12.11 Caption Care
  62. 12.11.1 Caption Care Company Information
  63. 12.11.2 Caption Care Business Overview
  64. 12.11.3 Caption Care Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026)
  65. 12.11.4 Caption Care Cardiac AI-assisted Diagnosis Product Portfolio
  66. 12.11.5 Caption Care Recent Developments
  67. 12.12 UltraSight
  68. 12.12.1 UltraSight Company Information
  69. 12.12.2 UltraSight Business Overview
  70. 12.12.3 UltraSight Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026)
  71. 12.12.4 UltraSight Cardiac AI-assisted Diagnosis Product Portfolio
  72. 12.12.5 UltraSight Recent Developments
  73. 12.13 Ultromics
  74. 12.13.1 Ultromics Company Information
  75. 12.13.2 Ultromics Business Overview
  76. 12.13.3 Ultromics Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026)
  77. 12.13.4 Ultromics Cardiac AI-assisted Diagnosis Product Portfolio
  78. 12.13.5 Ultromics Recent Developments
  79. 12.14 Cleerly
  80. 12.14.1 Cleerly Company Information
  81. 12.14.2 Cleerly Business Overview
  82. 12.14.3 Cleerly Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026)
  83. 12.14.4 Cleerly Cardiac AI-assisted Diagnosis Product Portfolio
  84. 12.14.5 Cleerly Recent Developments
  85. 12.15 Elucid
  86. 12.15.1 Elucid Company Information
  87. 12.15.2 Elucid Business Overview
  88. 12.15.3 Elucid Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026)
  89. 12.15.4 Elucid Cardiac AI-assisted Diagnosis Product Portfolio
  90. 12.15.5 Elucid Recent Developments
  91. 12.16 DiA Imaging Analysis
  92. 12.16.1 DiA Imaging Analysis Company Information
  93. 12.16.2 DiA Imaging Analysis Business Overview
  94. 12.16.3 DiA Imaging Analysis Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026)
  95. 12.16.4 DiA Imaging Analysis Cardiac AI-assisted Diagnosis Product Portfolio
  96. 12.16.5 DiA Imaging Analysis Recent Developments
  97. 12.17 Koninklijke Philips N.V
  98. 12.17.1 Koninklijke Philips N.V Company Information
  99. 12.17.2 Koninklijke Philips N.V Business Overview
  100. 12.17.3 Koninklijke Philips N.V Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026)
  101. 12.17.4 Koninklijke Philips N.V Cardiac AI-assisted Diagnosis Product Portfolio
  102. 12.17.5 Koninklijke Philips N.V Recent Developments
  103. 12.18 Fujifilm
  104. 12.18.1 Fujifilm Company Information
  105. 12.18.2 Fujifilm Business Overview
  106. 12.18.3 Fujifilm Revenue in Cardiac AI-assisted Diagnosis Business (2021-2026)
  107. 12.18.4 Fujifilm Cardiac AI-assisted Diagnosis Product Portfolio
  108. 12.18.5 Fujifilm Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst